2 case reports of cutaneous angiosarcomas under combined immunotherapy with ipilimumab/nivolumab

Yervoy (ipilimumab) - BMS

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

Ulrike Leiter-Stöppke; Kathrin Singvogel; Andreas Meiwes; Karl Georg Simon Frey; Marie-Lena Rasch

Sep 7, 2026